Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Remix Therapeutics

Remix Therapeutics

Small molecule therapies designed to reprogram RNA processing

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
CEO
Peter Smith
Peter Smith
0
Company Operating Status
Active
Competitors
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc.
Cedilla Therapeutics
Cedilla Therapeutics
Tango Therapeutics
Tango Therapeutics
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@remixtx.com
Founded Date
2018
Founder
Peter Smith
Peter Smith
0
Kevin Bitterman
Kevin Bitterman
Full Address
One Kendall Square, Building 600, Cambridge, MA 02139
0
Funding Type
Series B Round
Series B Round
Industry
RNA-based and RNA-targeted therapeutics
RNA-based and RNA-targeted therapeutics
Biology
Biology
Biotechnology
Biotechnology
RNA
RNA
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Technology
Technology
Investors
The Column Group
The Column Group
0
Atlas Venture
Atlas Venture
Foresite Capital
Foresite Capital
ARCH Venture Partners
ARCH Venture Partners
The Column Group
The Column Group
Alexandria Venture Investments
Alexandria Venture Investments
Casdin Capital
Casdin Capital
Surveyor Capital
Surveyor Capital
Latest Funding Round Date
May 18, 2022
Latest Funding Round Amount (USD)
70,000,000
Latest Funding Type
Series B Round
Series B Round
LinkedIn URL
@company/remix-therapeutics
Location
United States
United States
Cambridge, Massachusetts
Cambridge, Massachusetts
0
Number of Employees (Ranges)
51 – 200
Pitchbook URL
pitchbook.com/profiles...442833-04
Total Funding Amount (USD)
151,000,000
Twitter URL
@RemixThera
Official Website
remixtx.com

Find more companies like Remix Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo